The dicarboxylic amino acids L-glutamate and L-aspartate are considered to be the major fast-acting neurotransmitters at excitatory synapses in the mammalian central nervous system (CNS) [ l ] . In addition, they are cytotoxic [2] and also epileptogenic, when administered focally into the brain or systemically in high doses [3]. Their actions are mediated by at least three receptor subtypes, generally designated with respect to the selective agonists N-methyl-D-aspartate (NMDA), quisqualate (QUIS), and kainate (KA) [ 11. Moreover, these same receptors, which mediate direct neuronal depolarization, are also thought to be involved in neuronal injury following excessive or prolonged excitatory pathway stimulation [4]. Thus, excitatory-amino-acid (EAA)-induced neuronal degeneration is strongly suspected as the major culprit in a number of human neuropathological disorders of uncertain aetiology, e.g. epilepsy, stroke, Huntington's chorea.
The dicarboxylic amino acids L-glutamate and L-aspartate are considered to be the major fast-acting neurotransmitters at excitatory synapses in the mammalian central nervous system (CNS) [ l ] . In addition, they are cytotoxic [2] and also epileptogenic, when administered focally into the brain or systemically in high doses [3] . Their actions are mediated by at least three receptor subtypes, generally designated with respect to the selective agonists N-methyl-D-aspartate (NMDA), quisqualate (QUIS), and kainate (KA) [ 11. Moreover, these same receptors, which mediate direct neuronal depolarization, are also thought to be involved in neuronal injury following excessive or prolonged excitatory pathway stimulation [4] . Thus, excitatory-amino-acid (EAA)-induced neuronal degeneration is strongly suspected as the major culprit in a number of human neuropathological disorders of uncertain aetiology, e.g. epilepsy, stroke, Huntington's chorea.
Although the majority of evidence points towards glutamate (and aspartate), it is generally accepted that in a number of cases, the endogenous molecules which activate excitatory amino acid receptors in the CNS under both normal and pathological conditions have yet to be definitively identified. Thus, the actions and physiological role of other endogenous neuroactive compounds, namely quinolinic acid, y-glutamyl peptides and acidic sulphur-containing amino acids (SAAs) are currently being investigated by various groups.
A number of observations have prompted considerable recent interest in the study of neuroactive SAAs which have generated an increased awareness of a possible functional role for these compounds in the CNS. The SAAs comprise the excitatory acidic compounds, namely L-cysteine sulphinate (CSA), L-cysteate (CA), L-homocysteine sulphinate (HSA), L-homocysteate (HCA) and S-sulpho-L-cysteine (SC) and the inhibitory compounds, taurine and hypotaurine. The main theme of this paper involves only discussion on current studies of the excitatory acidic SAAs, since these compounds, all of which bear a strong structural resemblance to glutamate or aspartate, exhibit both excitotoxic and epileptogenic properties, and are therefore considered as transmitter candidates.
The process of neurotransmission involves biosynthesis and metabolism, evoked release, and receptor interaction, as well as physiological inactivation by high-affinity uptake into neurons and astrocytes. Support for the proposed role of the SAAs as transmitter candidates arises from a number of investigations. Thus: (i) in electrophysiological studies it has been shown that both L-and D-enantiomers of the SAAs excite central neurons in a manner similar to the excitation induced by glutamate and aspartate [S-71; moreover, these *To whom correspondence and reprint requests should be addressed.
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Biosynthesis ofneirroactive SAAs
The biosynthetic route of ncuroactive SAAs in mammalian brain originates from catabolism of the essential amino acid, methionine (Fig. 1 ) . In a series o f enzymic reactions, methionine is demethylated to homocysteinc. which lies at a metabolic branch point. The route through trutissulphuration yields cysteine. In brain, cysteine is oxidized by the enzyme, cysteine dioxygenase to CSA, which in turn undergoes rapid further metabolism either by decarboxylation to hypotaurine, oxidation to CA (which is further decarboxylated to taurine) or transamination to P-sulphinyl pyruvate. The neuroactive SAA. SC lies along the metabolic pathway between P-sulphinyl pyruvate and its end-product, inorganic sulphate. Transamination of CSA also represents a minor biosynthetic route o f glutamate [and y-aminobutyric acid (GABA)]. Although the endogenous location of HSA and HCA are established, their biosynthetic route from homocysteine is obscure and is presented here (Fig. 1 ) only by analogy to the metabolism of cysteine.
It has been recognized that SAA metabolism in the brain may be ultimately involved in the regulation of excitability by excitatory and inhibitory amino acids [ 171. As seen from Fig.  1 , these amino acids exist in a mutually close metabolic relationship in that decarboxylation of excitatory amino acids yields those that exhibit inhibitory properties. Since the concentration ratios of all these intermediates can be markedly altered by slight modification of enzyme activity, they may represent major determinants of brain excitability.
SAA-evoked neiirotratismitter release
A variety of techniques, such as intracerebral microdialysis, superfusion of tissue slices, cells or subcellular fractions, have been employed to study evoked release of amino acid neurotransmitters. These studies have provided important information regarding not only the mechanism and regulation of the release of neurotransmitters but also about the influence of different pathological conditions on The neuroexcitatory SAAs (CSA. CA. HSA. H C A and SC'), in addition to SO mM-K' or SO pM-veratridine, evoke the release of previously accumulated u-[ 'H laspartate (used ;is ;I non-metabolizable analogue of 1.-glutamate) from rat brain cerebrocortical and cerebellar synaptosomes in ii niiinncr that is wholly Ca"-independent Indeed, when the equilibrium ratio of the 1 't1Jtetraphenyl-phosphonium cation (I 'HITPP+ ) is used t o monitor membrane potential in synaptosome fractions, 1.-glutamate and all SAAs evoke a change in the distribution equivalent t o ii 5-10 mV disturbance of the equilibrium potential. This change may appear small in relation t o the synaptosomal population; however. if a s has been suggested 1261. the membrane potential changes within the preparation arc restricted t o the glutamatergic subpopulation o f synaptosomes. then an appreciable depolarization of this subpopulation may be effcc ted.
A possible involvement o f receptor activation in the mechanism of SAA-evoked release of previously accumulated D-[ 'H]aspartate. and o f endogenous 1.-glutamate and I.-aspartate. was investigated making use o f I:AA antagonists of the NMDA and non-NMDA receptor subtypes. Thus the specific antagonists of the NMDA receptor. 3-11 f )-2-carboxypiperazin-4-yI I-propyl-I-phosphonic acid (CPP), and non-NMDA receptor, 6-cyano-7-dinitroquinoxalineVol. 1 8 dione (CNQX), and the broad spectrum EAA antagonist kynurenate ( K Y N ) were totally ineffective, even at 1 mM concentrations, in attenuating the evoked release of either exogenously supplied or endogenous transmitter; while a similar concentration of DL-aminophosphonobutyric acid (DL-APB), an agonist at the presumed CI ~ dependent presynaptic receptor, exerted no effect on SAA-evoked transmitter release. It would appear, therefore, that glutamatergic nerve terminals do not express autoreceptors for SAAs which are characteristic of the NMDA, QUIS, KA or APB subtypes.
In the absence of any evidence t o support presynaptic receptor involvement in SAA-evoked Ca?' -dependent release of L-glutamate from synaptosomes, an alternative mechanism must be proposed which can also be explained in terms of reversal of the electrogenic Na' -coupled glutamate transporter. Thus it is conceivable that the depolarization induced by co-transport of SAA and Na+ could activate voltage-gated Ca' ' channels with consequent Ca' + -dependent release.
An essentially analogous picture emerges when studying SAA-evoked GABA release 1201. Thus, all SAAs studied, with the exception o f HCA, evoked the release of previously accumulated (7HIGABA (used in conjunction with the GABA-T inhibitor, y-vinyl-GABA, t o prevent GABA degradation) by a mechanism shown to comprise both a Ca?
+ -dependent and -independent component. As with glutamate/aspartate release, neither the SAAevoked release of endogenous GABA nor exogenously supplied 13H]GABA was attenuated at millimolar concentrations of either CPP or CNQX, thus suggesting a lack of NMDA, QUlS o r KA receptor involvement in mediating the Ca? + -dependent component of GABA release. Nevertheless, the demonstration of a Ca? + -dependent component of release is still consistent with activation of voltage-gated Ca?' channels. Since GABA is also transported via a highly active electrogenic Na'-coupled carrier 1251, it is tempting t o speculate that the SAA-evoked Ca?' -dependent component of GABA release may also be explained by activation of voltage-gated Ca?+ channels after depolarization induced by electrogenic co-transport of SAA with Na+. This mechanism suggests an interaction of SAAs with the GABA transporter. However, in view of the fact that SAAs do not inhibit GABA uptake in synaptosome fractions to any appreciable extent (R. Griffiths, unpublished work), this suggestion may seem unlikely.
Alternatively, and in view of the heterogeneous nature o f synaptosomal preparations, it is difficult to disprove the suggestion that GABAergic synaptosomes possess distinct highaffinity uptake systems for the SAAs through which electrogenic cotransport (with Na' j might occur. In support of this suggestion, the existence of high-affinity uptake systems for both glutamate and GABA in primary cultures of cortical neurons (GABAergic) has been demonstrated [27] . The role of carrier reversal in explanations o f SAAevoked release of amino acid neurotransitters from synaptosomes may be investigated by evoking release (i) in the presence of blockers of either the GABA transporter ( e g using SKF 89976-A [28]) or the glutamate transporter (e.g. using dihydrokainate (291) and (ii) by substitution of Na' with Li+ or choline. Such studies have, as yet, only been undertaken using primary cultures of neurons (see next section), but clearly show that Ca"-independent release in such cultures is due to reversal of the respective uptake systems.
Evoked releuse from primary tieuronul cultures
A continuous superfusion system [30] has been used to study the SAA-evoked release of, respectively, D-['Hlaspartate from mouse cerebellar granule (glutamatergic) cells and [ ZHJGABA from mouse cortical (GABAergic) neurons. It has been shown 13 1 for both cell types that all SAAs tested evoke a dose-dependent, saturable release o f previously accumulated 3H-labelled neurotransmitter exhibiting half-maximal stimulation (EC,,,) + -independent component o f release. has also been studied in some detail. Previously, very little effort has been applied to understanding more about the Ca' '-independent component of release, since this has been considered t o be of little functional significancc in the process o f neurotransmission. It was stated earlier that Ca' +-independent release might represent a reversal of the high-affinity plasma membrane carrier which functions normally in the direction o f amino acid re-uptake.
The importance of EAA/SAA-evoked Ca' +-independent release may be greater under pathological conditions where extracellular levels of certain neuroactive amino acids may be elevated. Thus, even those SAAs with low potency at EAA receptors may, because of their extracellular level. exert considerable influence o n neurotransmitter release by acting as substrates for the transporter thereby inducing a Ca' +-independent release. It should be remembered, however, that the depolarization generated by accumulation o f SAA and associated inward Na' flux could. in the presence of extracellular Ca?+, also result in additional Ca?
Under Ca' +-free conditions, and using agonist concentrations 2-3 times their EC5,, values, it is possible t o amplify the Ca"-independent component of release in order t o facilitate investigation and quantification o f effects. Thus, the SAAevoked Ca? + -independent release of D-I 'H laspartate from granule cells and [3H]GABA from cortical neurons can be shown to be markedly attenuated or even abolished (J. Dunlop et ul., unpublished work) when carrying o u t superfusion in the presence of 1 mM-dihydrokainate o r IS p~-SKF-89076-A, which function as effective non-transportable inhibitors of, respectively, the glutamate and GABA high-affinity rc-uptake carriers. Furthermore. this SAA-evoked rcleasc was sensitive to replacement of N a + in the supcr-I'usion mcdiuin. In contrast. I:AA receptor antagonists had no significant effect on the SAA-evoked release in the ahscnce of <'a2 + . These observations are clearly consistent with ('a2 + -indcpcndent release arising from reversal o f the transport carriers for the amino acid neurotransmitters.
An attempt has been made to demonstrate that SAAcvokcd depolarization is coupled t o release o f the transmitter amino acids from primary neuronal cultures. In both cell types. all SAAs inhibited t o varying extents the intracellular accumulation of [ 'HITPP', by amounts which could he interpreted (when compared with the change evoked by 25 niM K ' ) as being consistent with at least partial depolariration o f the plasma membrane. T h e extent t o which this alteration o f 1 'H ITPP' distribution arises from ( i ) rcccptor occupation and (ii) electrogenic co-transport is currently k i n g investigated. (Lodge, I)., ed.1 
